other material
confidence high
sentiment neutral
materiality 0.70
Regen Biopharma issues 101.9M Series A Preferred and 16.9M common shares in debt-for-equity swap
Regen BioPharma Inc
- Issued 101,880,008 shares of Series A Preferred to satisfy $511,500 convertible debt and $253,816 accrued interest.
- Issued 16,912,946 common shares to satisfy $25,369 accrued interest on a convertible note.
- Total debt and interest converted: $790,685 ($511,500 principal + $279,185 interest).
- Securities issued under Section 4(a)(2) private placement exemption; no underwriters or commissions.